A Study of GNC-035, a Tetra-specific Antibody, in Participants With Relapsed/Refractory Hematologic Malignancy
Clinical trial NCT05104775 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05104775
- Sponsor
- Sichuan Baili Pharmaceutical Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-09
- Primary completion
- 2025-12-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.